Search Results for

*

1-4 of 4 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Medications for Weight Loss in Patients with Type 2 Diabetes Mellitus - FPIN's Clinical...

Mar 15, 2012 - Fluoxetine (Prozac) and orlistat (Xenical) produce modest short-term weight loss, but their long-term benefits are unclear and their safety is uncertain.

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2012/0315/p633.html

Appetite Suppressants as Adjuncts for Weight Loss - FPIN's Clinical Inquiries - ...

Apr 1, 2011 - Phentermine and diethylpropion are appetite suppressants approved for use in the United States as adjuncts in the treatment of obesity. These agents demonstrate a modest weight loss benefit when combined with dietary modifications and exercise.

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2011/0401/od1.html

Thiazolidinedione Therapy for Managing Metabolic Syndrome - FPIN's Clinical Inquiries -...

Dec 15, 2010 - There is no patient-oriented evidence supporting the use of TZD therapy in patients in the general population who have metabolic syndrome. Rosiglitazone (Avandia) use decreases cardiovascular morbidity and mortality in patients with metabolic syndrome who are undergoing coronary stenting.

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2010/1215/p1553.html

Is Fluoxetine an Effective Therapy for Weight Loss in Obese Patients? - FPIN's Clinical...

Dec 15, 2003 - Fluoxetine (Prozac) use may result in an average, short-term weight loss of up to 3.3 kg (7 lb, 4 oz) in obese patients, but the longterm effects and maintenance of weight loss after discontinuation of the drug have not been well studied. No evidence concerning other SSRIs was found.

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2003/1215/p2437.html

Page  1

25 50 100 results per page